Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1999; 34:1569-1576
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ammer, R.
Right arrow Articles by Alt, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ammer, R.
Right arrow Articles by Alt, E.

Marked reduction in atrial defibrillation thresholds with repeated internal cardioversion

Richard Ammer, MDa,b, G.ünter Lehmann, MDa,b, Andreas Plewan, MDa,b, Katja Puetter, MDa,b and Eckhard Alt, MD

a Medizinische Klinik, Klinikum Rechts der Isar der Technischen Universität München, Munich, Germany
b Deutsches Herzzentrum, Klinik an der Technischen Universität, Munich, Germany



View larger version (27K):

[in a new window]
 
Figure 1 Study design for first and second internal cardioversion of chronic and recurrent AF. Beginning with a test shock of 60-V intensity, the voltage was increased in 40-V steps until cardioversion was achieved or to a maximum voltage of 580/240 V. The patients were sedated orally with 2.5 to 5 mg diazepam. Immediately before cardioversion, 1 mg midazolam was administered intravenously. Patients were asked to quantify their level of perceived pain by means of a scale ranging from 0 (= not felt) to 10 (= intolerable) after each shock applied.

 


View larger version (31K):

[in a new window]
 
Figure 2 Changes in duration of AF (in days), defibrillation thresholds (in J), pain scores (measured by means of a scale ranging from 0 = not felt to 10 = intolerable) and dosage of midazolam (in mg) for repeated internal cardioversion (n = 18): Comparison between first (open symbols) and second cardioversion (filled symbols) with respect to defibrillation vectors (right atrium-coronary sinus [triangles], right atrium-pulmonary artery [circles]).

 


View larger version (28K):

[in a new window]
 
Figure 3 Correlation between duration of AF (in days) before successful internal cardioversion and defibrillation thresholds (in J) for first (open symbols) and second (filled symbols) cardioversion of AF with respect to defibrillation vectors. (Top) Right atrium-coronary sinus (triangles). (Bottom) Right atrium-pulmonary artery (circles).

 


View larger version (26K):

[in a new window]
 
Figure 4 Correlation between defibrillation thresholds (in J) for first (open symbols) and second (filled symbols) internal cardioversion and pain scores (measured by means of a scale ranging from 0 = not felt to 10 = intolerable) at successful internal cardioversion of chronic and recurrent AF with respect to defibrillation vectors. (Top) Right atrium-coronary sinus (triangles). (Bottom) Right atrium-pulmonary artery (circles).

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement